Valo Health is a cutting-edge technology company focused on revolutionizing drug discovery and development through its Opal Computational Platform™, which combines machine learning, tissue biology, and patient data.

Valo Health

Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate. The company’s Opal Computational Platform™ consists of an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease. 

PSP Investments

Longevity Vision Fund

Koch Disruptive Technologies

Atinum Investment

HBM Healthcare Investments AG

E Squared Capital Management

Invus

Flagship Pioneering

Mirae Asset Capital

COM:VALOHEALTH

Valo Health